POSEIDA THERAPEUTICS INC shareholders Q2 2024

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 93 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

POSEIDA THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Russell Investments Group, Ltd. 38,741$113,1220.00%
VOYA INVESTMENT MANAGEMENT LLC 24,627$71,9110.00%
ALLIANCEBERNSTEIN L.P. 41,960$122,5230.00%
RHUMBLINE ADVISERS 97,012$283,2670.00%
PRINCIPAL FINANCIAL GROUP INC 12,006$35,0580.00%
VANGUARD GROUP INC 3,405,805$9,944,9510.00%
PRUDENTIAL FINANCIAL INC 19,980$58,3420.00%
LAZARD ASSET MANAGEMENT LLC 331$00.00%
GEODE CAPITAL MANAGEMENT, LLC 1,622,575$4,738,8930.00%
ROYAL BANK OF CANADA 7,684$23,0000.00%
AQR Capital Management 51,741$151,0840.00%
MARSHALL WACE, LLP 10,538$30,7710.00%
BlackRock Finance, Inc. 4,905,160$14,323,0670.00%
Bank of New York Mellon Corp 228,700$667,8040.00%
Citadel Advisors 134,700$393,3240.00%
Citadel Advisors 11,100$32,4120.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 281,900$823,1480.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 31,600$92,2720.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 16,006$46,7380.00%
Verition Fund Management LLC 10,673$31,1650.00%
External links

This page lists POSEIDA THERAPEUTICS INC's shareholders in Q2 2024. To view POSEIDA THERAPEUTICS INC's shareholder history, click here.